Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $82,461,833    

Indirect Value

  $12,984,280,034      
Total Shares   142,789,105      
Total Value   $13,066,741,867      


Incyte Corp
 $32,925,824 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $318,573 Neurogene
 $16,634 Incyte Corp
 $32,925,824 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $318,573 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 42 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
GHDX Genomic Health Inc Director   –       •       •   2008-06-09 4 B $19.61 $303,149 I/I 15,419 1,226,119 2.25 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2008-11-20 4 B $1.00 $303,517 I/I 303,517 4,309,994 1.5 -
SGEN Seagen Inc Director   –       •       •   2008-03-13 4 B $7.93 $304,356 I/I 38,404 7,690,417 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2009-02-04 4 S $8.01 $305,386 I/I (36,586) 228,113 0 -
SGEN Seagen Inc Director   –       •       •   2005-04-29 4 B $3.99 $307,022 I/I 76,759 228,556 2.25 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-11-07 4 S $12.66 $308,642 I/I (24,383) 575,768 0 -
SGEN Seagen Inc Director   –       •       •   2011-12-30 4 OE $6.25 $309,769 I/I 49,563 450,461 0 -
SGEN Seagen Inc Director   –       •       •   2006-06-28 4 B $4.02 $310,726 I/I 77,345 1,372,718 2.25 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-11-15 4 S $11.77 $311,031 I/I (26,415) 1,100,592 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-12-06 4 S $12.35 $311,323 I/I (25,202) 1,004,905 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-02-15 4 B $54.16 $314,099 I/I 5,800 14,369,871 2.25 %
SGEN Seagen Inc Director   –       •       •   2005-03-23 4 B $4.96 $314,315 I/I 63,376 133,975 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2006-02-28 4 S $19.90 $315,218 I/I (15,707) 103,540 -
INCY Incyte Corp Director   –       •       •   2011-12-01 4 B $13.78 $315,958 I/I 22,380 288,767 2.25 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2007-12-19 4 B $13.25 $317,576 I/I 23,968 43,108 1.5 -
INCY Incyte Corp Director   –       •       •   2008-12-19 4 B $3.60 $321,154 I/I 89,241 3,475,840 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-03-02 4 B $29.52 $323,899 I/I 10,972 1,461,872 2.25 -
KOD Kodiak Sciences Inc. Director   –       •       •   2022-01-25 4 B $58.90 $323,934 I/I 5,500 14,027,837 2.25 %
SGEN Seagen Inc Director   –       •       •   2005-04-29 4 B $3.99 $326,985 I/I 81,750 346,523 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2010-04-29 4 B $12.98 $328,600 I/I 25,243 229,394 1.5 -
INCY Incyte Corp 10% Owner   –       –       •   2003-09-22 4 B $4.97 $329,617 I/I 66,300 1,479,155 1.5 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2006-12-26 4 B $4.00 $331,992 I/I 82,998 854,210 1.5 -
INCY Incyte Corp Director   –       •       •   2008-01-11 4 B $10.94 $335,548 I/I 30,682 5,393,032 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2007-06-21 4 S $5.55 $342,460 I/I (61,690) 6,011,855 0 -
SGEN Seagen Inc Director   –       •       •   2009-05-20 4 B $9.72 $342,659 I/I 35,253 400,898 2.25 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42  43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 42 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed